<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Keneni DA</submitter><funding>South African National Research Foundation</funding><funding>NRF African Coelacanth Ecosystem Programme</funding><funding>German Academic Exchange Service</funding><funding>Deutscher Akademischer Austauschdienst France</funding><funding>South African Medical Research Council</funding><funding>German Academic Exchange Service France</funding><funding>DAAD</funding><pagination>e202500392</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12640659</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(22)</volume><pubmed_abstract>Marine sponges of the genus Oceanapia are prolific producers of bioactive secondary metabolites. Four known bifunctional sphingolipids are isolated: isorhizochalin (1), rhizochalin (2), rhizochalin C (3), and oceanapiside (4) from Oceanapia ramsayi sponges. These compounds are derivatized to form aglycones (1b-4b), perbenzoates (1c-4c), and bis-oxazoline (2e). The compounds and their derivatives are investigated for their cytotoxicity against three breast cancer cell lines (HCC70, MDA-MB-231, MCF7). All four sphingolipids are cytotoxic with significant selectivity indices (SI) for the three breast cancer cells. Compound 1 has high selectivity against the HCC70 cell line, 4 against the MDA-MB-231 cells, and aglycon 4b against both the MDA-MB-231 and MCF7 cell lines, respectively, demonstrat</pubmed_abstract><journal>ChemMedChem</journal><pubmed_title>Dual Biological Potential: Anticancer and Antibacterial Activities of Bis-α, ω-Bifunctional Sphingolipids from the Marine Sponge Oceanapia ramsayi.</pubmed_title><pmcid>PMC12640659</pmcid><funding_grant_id>91700877</funding_grant_id><funding_grant_id>AMR DD96815</funding_grant_id><funding_grant_id>GUN: 97967</funding_grant_id><funding_grant_id>91758998</funding_grant_id><funding_grant_id>GUN: 87583</funding_grant_id><pubmed_authors>Swart T</pubmed_authors><pubmed_authors>Davison C</pubmed_authors><pubmed_authors>de la Mare JA</pubmed_authors><pubmed_authors>Dorrington RA</pubmed_authors><pubmed_authors>Kalinski JJ</pubmed_authors><pubmed_authors>Keneni DA</pubmed_authors><pubmed_authors>Isaacs M</pubmed_authors><pubmed_authors>Njanje I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dual Biological Potential: Anticancer and Antibacterial Activities of Bis-α, ω-Bifunctional Sphingolipids from the Marine Sponge Oceanapia ramsayi.</name><description>Marine sponges of the genus Oceanapia are prolific producers of bioactive secondary metabolites. Four known bifunctional sphingolipids are isolated: isorhizochalin (1), rhizochalin (2), rhizochalin C (3), and oceanapiside (4) from Oceanapia ramsayi sponges. These compounds are derivatized to form aglycones (1b-4b), perbenzoates (1c-4c), and bis-oxazoline (2e). The compounds and their derivatives are investigated for their cytotoxicity against three breast cancer cell lines (HCC70, MDA-MB-231, MCF7). All four sphingolipids are cytotoxic with significant selectivity indices (SI) for the three breast cancer cells. Compound 1 has high selectivity against the HCC70 cell line, 4 against the MDA-MB-231 cells, and aglycon 4b against both the MDA-MB-231 and MCF7 cell lines, respectively, demonstrat</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T18:48:37.495Z</modification><creation>2026-05-20T03:13:14.071Z</creation></dates><accession>S-EPMC12640659</accession><cross_references><pubmed>41183286</pubmed><doi>10.1002/cmdc.202500392</doi></cross_references></HashMap>